This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Stock | Broker Update |
| Admiral | Berenberg ups TP to 1090p from 1080p, sell |
| African Barrick Gold | Investec ups TP to 206p from 132p, sell |
| Aggreko | UBS cuts TP to 1550p from 1680p, neutral |
| Ashmore Group | Berenberg cuts TP to 350p from 375p, Hold |
| AstraZeneca | UBS ups TP to 4600p from 4150p, Buy |
| Aviva | JP Morgan ups TP to 528p from 491p, overweight |
| Devro | JP Morgan downgrades to neutral from overweight; TP to 297p from 357p |
| Grafton Group | Citigroup ups TP to 625p from 550p, sell |
| International Airlines Group | UBS ups TP to 495p from 475p, Buy |
| Lookers | Liberum ups TP to 170p from 150p, Buy |
| Polyus Gold International | JP Morgan cuts TP to 190p from 230p, neutral |
| Rentokil Initial | Cantor Fitzgerald ups TP to 160p from 140p, Buy |
| Shire | UBS ups TP to 3450p from 3180p, neutral |
| SOCO International | Morgan Stanley cuts TP to 385p from 410p, underweight |
| Wolseley | Morgan Stanley ups TP to 3625p from 3575p, overweight |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research